Clinical Trial Update: Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. [NA]

View source ↗

Summary

Terminated clinical trial comparing Essiac (ESIAK) to placebo to improve quality of life in women transitioning with breast or ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Essiac (ESIAK)

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Ovarian Cancer, Breast Cancer | NA | Status: TERMINATED